![Michael Adena](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Michael Adena is the founder of Datalytics Pty Ltd.
He held the title of Director-Statistics since the company's founding in 2009.
Aktive Positionen von Michael Adena
Unternehmen | Position | Beginn |
---|---|---|
Datalytics Pty Ltd.
![]() Datalytics Pty Ltd. Data Processing ServicesTechnology Services Part of Bit2win Srl, Datalytics Pty Ltd. is a boutique Australian consultancy that provides high-quality strategy, clinical and statistical analysis, and economic modeling to support reimbursement activities of pharmaceutical clients. The company was founded in 2009 by Michael Adena and Graham Kelly and is based in Canberra, Australia. Datalytics specializes in health technology assessment, including full or partial pharmaceutical benefits advisory committee (PBAC) submissions, systematic literature reviews, meta-analyses, indirect comparisons, and network meta-analyses. The Australian company also has extensive experience in biostatistics, designing and analyzing registry, chart audit, and other observational data sets, as well as supporting clinical trials. | Gründer | 01.01.2009 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Datalytics Pty Ltd.
![]() Datalytics Pty Ltd. Data Processing ServicesTechnology Services Part of Bit2win Srl, Datalytics Pty Ltd. is a boutique Australian consultancy that provides high-quality strategy, clinical and statistical analysis, and economic modeling to support reimbursement activities of pharmaceutical clients. The company was founded in 2009 by Michael Adena and Graham Kelly and is based in Canberra, Australia. Datalytics specializes in health technology assessment, including full or partial pharmaceutical benefits advisory committee (PBAC) submissions, systematic literature reviews, meta-analyses, indirect comparisons, and network meta-analyses. The Australian company also has extensive experience in biostatistics, designing and analyzing registry, chart audit, and other observational data sets, as well as supporting clinical trials. | Technology Services |